Documents

Discussions Technicals Seasonals Options

Syros Pharmaceuticals, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Syros Pharmaceuticals, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2024

Q3 2024

Oct 31, 2024

Quarterly report10-Q

Corporate Presentation

Sep 06, 2024

Slides

Q2 2024

Jul 31, 2024

Quarterly report10-Q

Earnings release8-K

Status Update

Jun 25, 2024

Slides

The Citizens JMP Life Sciences Conference

May 14, 2024

Slides

Q1 2024

May 14, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 27, 2024

Earnings release8-K

Annual report10-K

Study Result

Dec 06, 2023

Press release

Slides

Q3 2023

Nov 14, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 08, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 10, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 02, 2023

Annual report10-K

Earnings release8-K

Status Update

Dec 10, 2022

Slides

Q3 2022

Nov 14, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 09, 2022

Quarterly report10-Q

Earnings release8-K

M&A Announcement

Jul 05, 2022

Press release

Q1 2022

May 16, 2022

Quarterly report10-Q

2021

Q4 2021

Mar 15, 2022

Annual report10-K

2020

Q4 2020

Mar 04, 2021

Annual report10-K

2019

Q4 2019

Mar 05, 2020

Annual report10-K

2018

Q4 2018

Mar 07, 2019

Annual report10-K

2017

Q4 2017

Mar 12, 2018

Annual report10-K

2016

Q4 2016

Mar 20, 2017

Annual report10-K